Regeneron Careers Logo
  • Careers Home
  • Labor Condition Applications
  • Check Status
    • - US Regular Jobs
    • - Ireland Jobs
    • - US Temporary Jobs
Regeneron

YOU ARE NOW LEAVING REGENERON.COM.

The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

CANCEL CONTINUE

YOU ARE NOW LEAVING REGENERON.COM.

The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

CANCEL CONTINUE

YOU ARE NOW LEAVING REGENERON.COM.

The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

CANCEL CONTINUE

YOU ARE NOW LEAVING REGENERON.COM.

The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

CANCEL CONTINUE
  • Terms of Use
  • Privacy Policy
  • Social Media Terms of Engagement
  • Contact Us

CAREERS

Join our team and help turn science into life-changing medicine.

  • INVESTORS & MEDIA
      • News
      • Events & Presentations
      • Stock Information
      • Financial Information
      • Corporate Governance
      • FAQs
    • PATIENTS
    • MEDICAL PROFESSIONALS
    • SCIENTISTS
  • ABOUT US
      • Leadership
      • History
      • Collaborations
      • Industrial Operations
      • Locations
    • SCIENCE
      • Pipeline
      • Research Areas
      • Technology
      • Regeneron Genetics Center
      • Scientific Publications
  • MEDICINES
      • ARCALYST ® (rilonacept) Injection
      • DUPIXENT ® (dupilumab) Injection
      • EYLEA ® (aflibercept) Injection
      • KEVZARA ® (sarilumab) Injection
      • LIBTAYO ® (cemiplimab-rwlc) Injection
      • PRALUENT ® (alirocumab) Injection
    • CITIZENSHIP
      • Science Education
      • The Regeneron Science Talent Search
      • Sustainable Communities
      • Supporting Patients
      • Culture of Integrity
      • Grants
  • About Us
    • Leadership
    • History
    • Collaborations
    • Industrial Operations
    • Locations
  • Science
    • Pipeline
    • Research Areas
    • Technology
    • Regeneron Genetics Center
    • Scientific Publications
  • Medicines
    • ARCALYST ® (rilonacept) INJECTION
    • DUPIXENT DUPIXENT ® (dupilumab) INJECTION
    • EYLEA EYLEA ® (aflibercept) Injection
    • KEVZARA PRALUENT ® (sarilumab) INJECTION
    • PRALUENT PRALUENT ® (alirocumab) INJECTION
  • Citizenship
    • Science Education
    • Science Talent Search
    • Sustainable Communities
    • Supporting Patients
    • Culture of Integrity
    • Grants
  • Investors & Media
    • News
    • Events & Presentations
    • Stock Information
    • Financial Information
    • Corporate Governance
    • FAQs
  • Careers
  • Scientists
  • Patients
  • Medical Professionals
  • Terms of Use
  • Privacy Policy
  • Social Media Terms of Engagement
  • Ireland Site
  • Contact Us
823d26a1c7744c5eab0bc40cda4230ac